Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 16.06% is 10% above its 5-year average of 14.58%, near the high end of its 5-year range (-2.38%–23.07%).
152.12% above its 12-month average of 6.37%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
16.06%
RETURN ON ASSETS (ROA) AVG TTM
6.37%
RETURN ON ASSETS (ROA) AVG 3Y
11.74%
RETURN ON ASSETS (ROA) AVG 5Y
14.58%
RETURN ON ASSETS (ROA) AVG 10Y
10.58%
RETURN ON ASSETS (ROA) AVG 15Y
4.20%
RETURN ON ASSETS (ROA) AVG 20Y
-8.81%
CURRENT VS TTM AVG
+152.12%
CURRENT VS 3Y AVG
+36.80%
CURRENT VS 5Y AVG
+10.16%
CURRENT VS 10Y AVG
+51.77%
CURRENT VS 15Y AVG
+282.02%
CURRENT VS 20Y AVG
+282.36%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+212.45%
vs the sector median at left
Vertex Pharmaceuticals Incorporated
Market Cap
$133.02B
Return on Assets (ROA)
16.06%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
Market Cap
$132.54B
Return on Assets (ROA)
10.59%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$125.41B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$142.71B
Return on Assets (ROA)
4.33%
TTM Avg
4.68%
3Y Avg
5.89%
5Y Avg
6.01%
Market Cap
$120.12B
Return on Assets (ROA)
1.93%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$119.29B
Return on Assets (ROA)
5.61%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$158.87B
Return on Assets (ROA)
2.16%
TTM Avg
3.75%
3Y Avg
6.08%
5Y Avg
7.08%
Market Cap
$105.46B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$104.51B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $133.02B | 16.06% | 6.37% | 11.74% | 14.58% |
| Bristol-Myers Squibb Company (BMY)vs › | $132.54B | 10.59% | -0.92% | 3.28% | 1.99% |
| Intuitive Surgical, Inc. (ISRG)vs › | $125.41B | 15.04% | 13.09% | 12.00% | 11.68% |
| Danaher Corporation (DHR)vs › | $142.71B | 4.33% | 4.68% | 5.89% | 6.01% |
| CVS Health Corp. (CVS)vs › | $120.12B | 1.93% | 1.25% | 1.93% | 2.38% |
| Medtronic plc (MDT)vs › | $119.29B | 5.61% | 5.13% | 4.62% | 4.65% |
| Pfizer Inc. (PFE)vs › | $158.87B | 2.16% | 3.75% | 6.08% | 7.08% |
| Stryker Corporation (SYK)vs › | $105.46B | 7.78% | 6.88% | 7.02% | 6.41% |
| McKesson Corporation (MCK)vs › | $104.51B | 5.20% | 5.08% | 5.08% | 2.52% |
| Sanofi (SNY)vs › | $103.96B | 3.12% | 5.18% | 5.31% | 6.19% |
ROA
16.1%
ROE
21.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 15.12% |
| 2024-12-31 | -2.38% |
| 2023-12-31 | 15.92% |
| 2022-12-31 | 18.30% |
| 2021-12-31 | 17.44% |
| 2020-12-31 | 23.07% |
| 2019-12-31 | 14.15% |
| 2018-12-31 | 33.57% |
| 2017-12-31 | 7.43% |
| 2016-12-31 | -3.87% |
| 2015-12-31 | -22.35% |
| 2014-12-31 | -31.61% |
| 2013-12-31 | -19.19% |
| 2012-12-31 | -3.88% |
| 2011-12-31 | 1.34% |
| 2010-12-31 | -43.74% |
| 2009-12-31 | -32.81% |
| 2008-12-31 | -46.90% |
| 2007-12-31 | -65.05% |
| 2006-12-31 | -22.45% |
| 2005-12-31 | -37.05% |
| 2004-12-31 | -30.48% |
| 2003-12-31 | -27.16% |
| 2002-12-31 | -13.32% |
| 2001-12-31 | -7.16% |
| 2000-12-31 | -5.13% |
| 1999-12-31 | -17.64% |
| 1998-12-31 | -12.43% |
| 1997-12-31 | -6.70% |
| 1996-12-31 | -27.87% |
